Structure-based discovery of Ginkgo biloba derived inhibitors of EGFR: a multi-scale computational method for cancer therapy

Key Points

• Inhibitors of EGFR derived from Ginkgo biloba show promise in cancer therapy with significant potential impact.
• A computational method reveals binding interactions between EGFR and Ginkgo biloba-derived compounds.
• This approach integrates multi-scale computational techniques to screen for novel therapeutic compounds.
• Findings highlight the importance of natural product exploration in developing effective cancer treatments.